Key result
Intravenous adenosine rapidly terminated maternal paroxysmal supraventricular tachycardia in pregnant patients without maternal or fetal complications.
Why the study?
Does intravenous adenosine safely terminate paroxysmal supraventricular tachycardia in pregnant patients?
Case Report
Does intravenous adenosine safely terminate paroxysmal supraventricular tachycardia in pregnant patients?
Intravenous adenosine appears to be an effective and safe option for rapidly terminating paroxysmal supraventricular tachycardia during pregnancy.
May support adenosine for PSVT in pregnancy; leaves open need for larger prospective trials.
AbstractIntravenous adenosine is being used for the treatment of paroxysmal supraventricular tachycardia and paroxysmal junctional tachyarrhythmia in nonpregnant patients. In the cases presented here, intravenous adenosine rapidly terminated maternal paroxysmal supraventricular tachycardia in pregnant patients without maternal or fetal complications. Its potential advantages over other antiarrhythmics are discussed.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (1992) conducted a case report in Maternal paroxysmal supraventricular tachycardia. Intravenous adenosine was evaluated on Termination of tachycardia and maternal or fetal complications. Intravenous adenosine rapidly terminated maternal paroxysmal supraventricular tachycardia in pregnant patients without maternal or fetal complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: